Cargando…
Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease
Immune checkpoint inhibitors (ICIs) targeting programmed cell death 1 (PD-1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4) are widely used to treat advanced metastatic cancers. Neutralisation of PD-1 or CTLA-4 by ICIs results in immune-related adverse events (irAEs). The clinicopathological features...
Autores principales: | Hagiwara, Satoru, Watanabe, Tomohiro, Kudo, Masatoshi, Minaga, Kosuke, Komeda, Yoriaki, Kamata, Ken, Kimura, Masatomo, Hayashi, Hidetoshi, Nakagawa, Kazuhiko, Ueshima, Kazuomi, Minami, Yasunori, Aoki, Tomoko, Takita, Masahiro, Morita, Masahiro, Cishina, Hirokazu, Ida, Hiroshi, Park, Ah-Mee, Nishida, Naoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085223/ https://www.ncbi.nlm.nih.gov/pubmed/33927311 http://dx.doi.org/10.1038/s41598-021-88824-1 |
Ejemplares similares
-
Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
por: Hagiwara, Satoru, et al.
Publicado: (2021) -
Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma
por: Nishida, Naoshi, et al.
Publicado: (2023) -
Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma
por: Morita, Masahiro, et al.
Publicado: (2023) -
Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyria
por: Hagiwara, Satoru, et al.
Publicado: (2022) -
Exploratory Analysis of Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma Who Have Failed Prior PD−1/PD-L1 Checkpoint Blockade
por: Aoki, Tomoko, et al.
Publicado: (2020)